Again, welcome, everyone, to our earnings call for the full year of 2025. We made the announcement of our annual results this evening, Hong Kong time. Before we begin today's call, I would like to ...
Novartis AG faces major patent expiries but is buying pipeline assets to sustain growth. Click for this NVS update.
This voluntary announcement provides a brief overview of high-level operational performance indicators for the five months ended 28 February 2026 (‘review period’) ahead of Netcare’s participation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results